Inicio > Endocrinología y Nutrición > Factores de riesgo de diabetes mellitus tipo 2 en individuos predispuestos genéticamente > Página 5

Factores de riesgo de diabetes mellitus tipo 2 en individuos predispuestos genéticamente

76. Grundy SM, Cleeman JI, Daniels SR. American Heart Association; National Heart Lung and Blood Institute. Diagnosis and management of the Metabolic Syndrome. An American Heart Association/National Heart, Lung and Blood Institute Scientific Statement. Circulation. 2008; 112:2735-52.

77. Feig DI, Kang D, Richard J, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008; 359:1811-21.

78. European Society of Hypertension European Society of Cardiology Guidelines Committee: 2006. European Society of Hypertension-European Society of Cardiology. Guidelines for the management of arterial hypertension. J Hypertens. 2006; 21:1011-53.

79. Blood pressure lowering treatment trialist‛ collaboration Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adult: meta analysis on randomized trials. Rev. BMJ 2008; 336:1121-23.

80. Bangalore S, Messerli FH, Kostis JB, Pepine CJ. Cardiovascular protection using beta-blockers: A critical review of the evidence. J Am Coll Cardiol 2007; 50:563-72.

81. Mancia G. ESH update of previous guidelines. Presented at the 19th European Meeting on Hypertension; 2009 june 12-16 Milan, Italy.

82. National Collaborating Centre for Chronic Condition. Hypertension, management in adults in primary care pharmacological. 2009.

83. Contreras F, Rivera M, Vázquez F. Diabetes e hipertensión arterial, aspectos clínicos y terapéuticos. AVFT. 2009; 19(1):15-9.

84. Fernández-Real JM, Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocrine Reviews. 2010; 24:278-301.

85. Barcelo A, Pathaks R. Incidence and prevalence of diabetes mellitus in the Americas. Panamerican Journal of Public Health. 2010; 10(5):33-8.

86. Asociación Latinoamericana de Diabetes (ALAD). Buenos Aires, 4/03/2011

87. Sowers JR, Epstein M. Diabetes mellitus and associate hypertension, vascular disease and nephropathy. An update. Hypertension. 2007; 26:869-79.

88. Cooper RS, Orduñez P, Iraola MD, Bernal JL, Espinosa-Brito A. Cardiovascular disease and associated risk factors in Cuba: prospects for prevention and control. Am J Public Health. 2006; 96(2):94-101.

89. García R, Suárez R. La educación en Diabetes en Cuba. Vivir con diabetes. Revista Boliviana para Personas con Diabetes. 2005; 1

90. 31. Lorenzo E, Sánchez I, García R. Evaluación de una intervención educativa en un grupo de pacientes Diabéticos del Policlínico Luís de la Puente Uceda. Rev. Cubana Endocrinol. 2008; 12(Supl):77.

91. Aldana D, Domínguez E, Claveo AO. Evaluación de la atención a personas con diabetes en una comunidad villaclareña 2003-2004. Rev. Cubana Endocrinol. 2006; 12(Supl):39.

92. Valenciaga JL, Díaz O, Vega I, Sera R. Comportamiento clínico epidemiológico de la Diabetes Mellitus insulinodependiente. Policlínico Docente Güines Sur, provincia La Habana, Año 2007. Rev. CubanaEndocrinol. 2008; 12(Supl):24.

93. Campos A, Campos G, Morales C. Estilo de vida y complicaciones macrovasculares en ancianos diabéticos de un área de salud. Rev. Cubana Endocrinol. 2010; 12(Supl):46.

94. Zimmet P, Alberti KGM. The changing face of macrovascular disease in non-insulindependent diabetes mellitus: an epidemic in progress. Diabetes and the heart. Lancet. 2007; 350 (Suppl I):1-13.

95. Lindsay RS, Howard BV. Cardiovascular risk associated with the metabolic syndrome. Curr Diab Rep. 2010; 4(I):63-8.

96. Seli E, Duleba AJ. Treatment of PCOS with metformin and other insulin-sensitizing agents. Curr Diab Rep. 2009; 4(1):69-75.

97. Robinson LE, Van Soeren MH. Insulin resistance and hyperglycemia in critical illness: role of insulin in glycemic control. AACN Clin Issues. 2010; 15(1):45-62.

98. Diabetes Education Study Group of the European Association for the Study of Diabetes. In: Assal J Ph, Alivisator Jg, Halimi D, eds: The teaching letters. Introduction. ARTEM, France; 2009.p.1-3.

99. Uchiyama A, Shimizu T, Nakagawa T, Tanaka T. Association of hypertension with changes in the body mass index of university students. Environ Health Prev Med. 2008; 13(5):271-80.

100. www .forofarmaceutico.blogspot. intramed.net.Abril.2012

101. www.facebook.com/foro.farmaceutico.

102. Seuc A, Dguez E, Díaz O. Esperanza de vida ajustada por diabetes. Rev. Cubana Endocrinol. 2009; 14(3):80-90.

103. Emma Domínguez Alonso, Armando Seuc Jo; Oscar Díaz Díaz. Esperanza de vida saludable asociada a la diabetes en Cuba: años 1990 y 2003. Rev. Cubana Endocrinol v.21 n.1 Ciudad de la Habana ene.-abr. 2010